News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
138 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (3398)
February (3796)
March (4054)
April (4079)
May (4309)
June (3941)
July (3248)
August (3087)
September (3751)
October (3897)
November (3988)
December (2885)
Day
1 (229)
2 (123)
5 (188)
6 (202)
7 (166)
8 (191)
9 (122)
12 (138)
13 (226)
14 (221)
15 (198)
16 (126)
19 (181)
20 (189)
21 (155)
22 (184)
23 (129)
26 (166)
27 (219)
28 (197)
29 (207)
30 (140)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
Drug Development
Naia Limited Successfully Completes Pre-IND Meeting With U.S. FDA For NB1001, Long-Acting GLP-1 (XTEN-GLP-1) Receptor Agonist For Treatment Of Short Bowel Syndrome
October 12, 2015
·
4 min read
Drug Development
Allergan Release: Data Presented at IDWeek Reports AVYCAZ (ceftazidime and avibactam) Demonstrated In Vitro Antimicrobial Activity Against Common Enterobacteriaceae Pathogens, Including Certain Carbapenem-Resistant Strains
October 12, 2015
·
10 min read
Drug Development
Melinta Presents Complete Delafloxacin Results From Phase III Study In Patients With Acute Bacterial Skin And Skin Structure Infections At ID Week
October 12, 2015
·
5 min read
Drug Development
Phase II Dosimetry Data For Progenics Pharmaceuticals, Inc.’ AZEDRA Presented At EANM Congress 2015
October 12, 2015
·
5 min read
Drug Development
Proteon Therapeutics, Inc. Announces Results From Phase I Study Of Investigational Drug Vonapanitase In Patients With Symptomatic Peripheral Artery Disease Presented At TCT 2015
October 12, 2015
·
7 min read
Business
Pluristem Therapeutics & Charite Expand Cooperation Agreement To Include Orthopedic Indications
October 12, 2015
·
6 min read
Genetown
RXi Pharma To Present At Premier Scientific Plastic Surgery Meeting
October 12, 2015
·
6 min read
FDA
Gamma Medica Receives CE Mark for LumaGEM Molecular Breast Imaging System, a New Standard of Care in Breast Imaging
October 12, 2015
·
4 min read
Business
Amedica Corporation Breaks Into The Dental Market With Recent Joint Development Agreement
October 12, 2015
·
3 min read
3D Systems Expands Product Lines For Cardiology Training And Surgical Planning
October 12, 2015
·
4 min read
Previous
3 of 14
Next
